We examined whether antibody levels trended higher based on the number of days between symptom onset and sample collection but were unable to detect a clear trend, even after stratifying by number of vaccine doses received ( Appendix Figure 4), potentially because 50% of NAAT-positive case-patients had samples collected within 3 days of symptom onset and 90% within 6 days ( Appendix Table 1).
← all excerpts
Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022.
1
—
—